Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Immunovative Therapies, Ltd.)"
Count: 15
Selected: 0
| NCT ID | Title |
|---|
| NCT05033522 | Immunotherapy for Advanced Liver Cancer | ||
| NCT04444622 | Immunotherapy for Third Line Metastatic Colorectal Cancer | ||
| NCT04441047 | Universal Anti-Viral Vaccine for Healthy Elderly Adults | ||
| NCT02624999 | Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck | ||
| NCT02409524 | An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects | ||
| NCT02380443 | AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer | ||
| NCT02018419 | Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients | ||
| NCT01998542 | Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck | ||
| NCT01995227 | An Individualized Anti-Cancer Vaccine Study in Patients With HCC | ||
| NCT01923233 | In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer | ||
| NCT01741038 | AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer | ||
| NCT00861965 | Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers | ||
| NCT00861107 | In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation | ||
| NCT00558675 | A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy | ||
| NCT01065441 | Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer |
